EV/EBITDA
-0.13
-0.01-8.33%
21 min ago
Summary
- As of February 7, 2025, ENTO EV/EBITDA is -0.13, with a fall of -0.01 (-8.33%) during the most recent trading day.
- Over the past year, ENTO EV/EBITDA has increased by +0.24 (+64.86%).
- ENTO EV/EBITDA is now -360.00% below its all-time high of 0.05.
Performance
ENTO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
ENTO EV/EBITDA Trends
PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
---|---|---|---|
todaytoday | -8.3% | +7.0% | +6.4% |
1 m1 month | +23.5% | -22.5% | -21.1% |
3 m3 months | - | - | -16.7% |
6 m6 months | -62.5% | +52.1% | -5.3% |
ytdytd | +13.3% | -12.2% | -11.3% |
1 y1 year | +64.9% | -58.6% | -90.1% |
5 y5 years | +93.2% | -90.9% | -100.0% |
ENTO EV/EBITDA Highs & Lows
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1-month | -18.2% | -0.17 | +23.5% | |
3 m | 3-month | -0.09 | -44.4% | -0.21 | +38.1% |
6 m | 6-month | -0.02 | -550.0% | -0.21 | +38.1% |
1 y | 1-year | -0.02 | -550.0% | -0.73 | +82.2% |
3 y | 3-year | 0.05 | -360.0% | -0.86 | +84.9% |
5 y | 5-year | 0.05 | -360.0% | -3.91 | +96.7% |
alltime | all time | 0.05 | -360.0% | -8.70 | +98.5% |
Entero Therapeutics EV/EBITDA History
Date | Value |
---|---|
2025 | -0.13(-13.3%) |
2024 | -0.15(-34.8%) |
2023 | -0.23(-41.0%) |
2022 | -0.39(+62.5%) |
2021 | -0.24(-72.7%) |
Date | Value |
---|---|
2020 | -0.88(-56.2%) |
2019 | -2.01(+30.5%) |
2018 | -1.54(-68.0%) |
2017 | -4.82(0.0%) |
2016 | -4.82 |
FAQ
- What is Entero Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Entero Therapeutics?
- What is ENTO EV/EBITDA year-to-date change?
- What is Entero Therapeutics EV/EBITDA year-on-year change?
What is Entero Therapeutics EV/EBITDA?
The current EV/EBITDA of ENTO is -0.13
What is the all time high EV/EBITDA for Entero Therapeutics?
Entero Therapeutics all-time high EV/EBITDA is 0.05
What is ENTO EV/EBITDA year-to-date change?
Entero Therapeutics EV/EBITDA has changed by +0.02 (+13.33%) since the beginning of the year
What is Entero Therapeutics EV/EBITDA year-on-year change?
Over the past year, ENTO EV/EBITDA has changed by +0.24 (+64.86%)